Advanced Proteome Therapeutics Corporation (APTCF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -693.57 Thousand | -545.19 Thousand | -466.98 Thousand | -685.7 Thousand | -1.21 Million |
| Net Income | - | 597.48 Thousand | -1.92 Million | -541.49 Thousand | -461.36 Thousand | -892.88 Thousand |
| Depreciation & Amortization | - | 4637.00 | 2896.00 | 3243.00 | 4184.00 | 5829.00 |
| Deferred income taxes | - | - | 1.18 Million | -60.39 Thousand | -492.25 Thousand | -349.56 Thousand |
| Stock-based compensation | - | - | 132.42 Thousand | 28.11 Thousand | 80.53 Thousand | 101.03 |
| Change in working capital | - | 301.13 Thousand | -13.18 Thousand | 69.92 Thousand | 160.98 Thousand | -131.35 Thousand |
| Other non-cash items | - | -1.59 Million | 66.13 Thousand | 33.63 Thousand | 22.21 Thousand | 54.64 Thousand |
| Investing Cash Flow | - | -13.78 Thousand | -49.86 Thousand | - | -1393.00 | - |
| Investments in PPE | - | -13.78 Thousand | -1719.00 | - | -1393.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -48.14 Thousand | - | - | - |
| Financing Cash Flow | - | 429.43 Thousand | 1.41 Million | 337.42 Thousand | 683.35 Thousand | 1.2 Million |
| Debt repayment | - | -196.7 Thousand | -118.96 Thousand | -104.03 Thousand | -143.73 Thousand | -50.88 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 150.43 Thousand | 1.36 Million | 250.57 Thousand | 548.29 Thousand | 1.26 Million |
| Other Financing Activities | - | 475.7 Thousand | 167.1 Thousand | 190.89 Thousand | 278.8 Thousand | 1209.99 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 85.7 Thousand | -71.49 Thousand | 39.12 Thousand | 143.29 Thousand | -76.17 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 215.43 Thousand | 58.3 Thousand | 30.79 Thousand | 17.68 Thousand | -55.18 Thousand |
| Cash at beginning of period | 544.89 Thousand | 822.36 Thousand | 2426.00 | 131.97 Thousand | 135.71 Thousand | 138.03 Thousand |
| Cash at end of period | 544.89 Thousand | 544.42 Thousand | 822.36 Thousand | 2426.00 | 131.97 Thousand | 135.71 Thousand |
| Capital Expenditure | - | -13.78 Thousand | -1719.00 | - | -1393.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -277.93 Thousand | 819.93 Thousand | -129.55 Thousand | -3738.00 | -2318.00 |
| Free Cash Flow | - | -707.36 Thousand | -546.91 Thousand | -466.98 Thousand | -687.09 Thousand | -1.21 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | -2.09 Million | -332.79 Thousand | -258.52 Thousand |
| Depreciation & Amortization | - | - | - | 2524.00 | 1233.00 | 1166.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -540.00 | 140.7 Thousand | 48.31 Thousand |
| Other non-cash items | - | - | - | 1.37 Million | 70.32 Thousand | -43.22 Thousand |
| Investing Cash Flow | - | - | - | -99.68 Thousand | -35.79 Thousand | - |
| Investments in PPE | - | - | - | -675.00 | -675.00 | - |
| Acquisitions | - | - | - | -83.86 Thousand | - | - |
| Investment purchases | - | - | - | 83.86 Thousand | -85.38 Thousand | - |
| Sales/Maturities of investments | - | - | - | 214.74 Thousand | - | - |
| Other Investing Activities | - | - | - | -313.75 Thousand | 50.26 Thousand | - |
| Financing Cash Flow | - | - | - | 106.37 Thousand | 101.39 Thousand | - |
| Debt repayment | - | - | - | -45.45 Thousand | -45.24 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -40.41 | - | - |
| Common Stock Issuance | - | - | - | 15.39 Thousand | 56.14 Thousand | - |
| Other Financing Activities | - | - | - | 136.43 Thousand | 90.49 Thousand | - |
| Accounts receivables | - | - | - | 8396.00 | - | - |
| Accounts payables | - | - | - | -8936.00 | 135.86 Thousand | 46.27 Thousand |
| Inventory | - | - | - | 187.31 Thousand | - | - |
| Other working capital | - | - | - | -187.31 Thousand | 4834.00 | 2041.00 |
| Cash at beginning of period | - | 544.89 Thousand | 38.73 Thousand | 544.42 Thousand | 312.16 Thousand | 544.42 Thousand |
| Cash at end of period | - | 544.89 Thousand | 38.73 Thousand | 38.7 Thousand | 236.62 Thousand | 312.16 Thousand |
| Capital Expenditure | - | - | - | -675.00 | -675.00 | - |
| Effect of forex changes on cash | - | - | - | 199.36 Thousand | -20.6 Thousand | - |
| Net cash flow / Change in cash | - | - | - | -505.72 Thousand | -75.54 Thousand | -232.26 Thousand |
| Free Cash Flow | - | - | - | -712.45 Thousand | -121.21 Thousand | -252.26 Thousand |
9247
NGELF
ARGX
FTU
KALO
ISTLTD